The role of axonopathy in the mechanisms of development of demyelination processes in the central and peripheral nervous system

Springer Science and Business Media LLC - Tập 39 Số 1 - Trang 31-34 - 2009
Yu A Merkulov1,2,3, И. А. Завалишин1,2,3, D M Merkulova1,2,3
1Professor B. M. Gekht Center for the Diagnosis and Treatment of Peripheral Nervous System Diseases, Department of Health, RZhD OAO, Moscow, Russia
2State Research Institute of Neurology, Russian Academy of Medical Sciences, Moscow, Russia
3State Research Institute of Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow, Russia

Tóm tắt

Từ khóa


Tài liệu tham khảo

B. M. Gekht, L. F. Kasatkina, M. I. Samoilov, and A. G. Sanadze, Electromyography in the Diagnosis of Neuromuscular Diseases [in Russian], Taganrog Radiotechnical University, Taganrog (1997).

E. I. Gusev and A. N. Boiko, Multiple Sclerosis: from Studies of Immunopathogenesis to New Methods of Treatment [in Russian], Gubernskaya Meditsina, Moscow (2001).

I. A. Zavalishin, A. V. Peresedova, L. S. Musaeva, and T. D. Zhuchenko, “Lateral amyotrophic sclerosis,” in: Neurodegenerative Diseases and Aging [in Russian], I. A. Zavalishin, N. N. Yakhno, and S. I. Gavrilova (eds.), Meditsina, Moscow (2001).

I. A. Zavalishin and M. N. Zakharova, “Multiple sclerosis: basic aspects of pathogenesis,” in: Multiple Sclerosis and Other Demyelinating Diseases [in Russian], E. I. Gusev, I. A. Zavalishin, and A. N. Boiko (eds.), Mikhlosh, Moscow (2004), pp. 60–74.

N. N. Spirin, E. G. Beznisko, and N. A. Marinichev, “Pain syndrome and pathology of the musculoskeletal apparatus in multiple sclerosis,” in: Multiple Sclerosis and Other Demyelinating Diseases [in Russian], E. I. Gusev, I. A. Zavalishin, and A. N. Boiko (eds.), Mikhlosh, Moscow (2004), pp. 217–232.

T. E. Shmidt and N. N. Yakhno, Multiple Sclerosis [in Russian], Meditsina, Moscow (2003).

S. E. Abbey and P. E. Garfinkel, “Neurasthenia and chronic fatigue syndrome: the role of culture in the making of a diagnosis,” Amer. J. Psychiat., 148, 1638–1646 (1991).

M. Almsaddi, T. E. Bertorini, and W. K. Seltzer, “Demyelinating neuropathy in a patient with multiple sclerosis and genotypical HMSN-1,” Neuromusc. Disord., 8, 87–89 (1998).

R. Bakshi, “Fatigue associated with multiple sclerosis: diagnosis, impact and management,” Mult. Scler., 9, 219–227 (2003).

F. Barkhof, “The role of magnetic resonance imaging in diagnosis of multiple sclerosis,” in: Multiple sclerosis: Clinical Challenges and Controversies, A. J. Thompson, C. Polman, and R. Hohfeld (eds.), Martin Dunitz (1997), pp. 43–64.

A. Bitsch, J. Schuchardt, S. Bunkowski, et al., “Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation,” Brain, 123, 1174–1183 (2000).

F. Dangond, Disorders of Myelin in the Central and Peripheral Nervous Systems, Butterworth Heinemann (2002).

N. De Stefano, S. Narayanan, G. S. Francis, et al., “Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability,” Arch. Neurol., 58, 65–70 (2001).

R. Djaldetti, I. Ziv, A. Achrion, and E. Melamed, “Fatigue in multiple sclerosis compared with chronic fatigue syndrome: a quantitative assessment,” Neurology, 46, 632–635 (1996).

P. J. Dyck, “Detection, characterization and staging of polyneuropathy: assessed in diabetics,” Muscle Nerve, 11, 21–32 (1988).

P. J. Dyck, J. Prineas, and J. Pollard, “Chronic inflammatory demyelinating polyradiculoneuropathy,” in: Peripheral Neuropathy P. J. Dyck, P. K. Thomas, J. W. Griffin, et al. (eds.), W. B. Saunders, Philadelphia, Third Edition (1993), pp. 1498–1517.

M. Filippi, P. Rossi, and A. Campi, “Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability,” AJNR, 18, 1549–1556 (1997).

O. Gonen, I. Catalaa, J. S. Babb, et al., “Total brain N-acetylaspartate: A new measure of disease load in MS,” Neurology, 54, 15–20 (2000).

M. Hamilton, “Development of rating scale for primary depressive illness,” Brit. J. Soc. Clin. Psychol., 6, 278–296 (1967).

J. Kimura, “Consequences of peripheral nerve demyelination: basic and clinical aspects,” Can. J. Neurol. Sci., 20, 263–270 (1993).

L. B. Krupp, L. A. Alvarez, N. G. LaRocca, and L. C. Scheinberg, “Fatigue in multiple sclerosis,” Arch. Neurol., 45, 435–437 (1988).

L. B. Krupp, N. G. LaRocca, J. Muir-Nash, and A. D. Steinberg, “The fatigue severity scale,” Arch. Neurol., 46, 1121–1123 (1989).

J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurology, 33, 1444–1452 (1983).

W. I. McDonald, A. Compston, G. Edan, et al., “Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis,” Ann. Neurol., 50, 122–127 (2001).

J. F. Nielsen and P. Norgaard, “Increased post-exercise facilitation of motor evoked potentials in multiple sclerosis,” Clin. Neurophysiol., 113, 1295–1300 (2002).

M. C. Tartaglia, S. Narayanan, S. J. Francis, et al., “The relationship between diffuse axonal damage and fatigue in multiple sclerosis,” Arch. Neurol., 61, 201–207 (2004).

L. Truyen, J. H. van Waesberghe, M. A. van Walderveen, et al., “Accumulation of hypointense lesions (“black holes”) on T1 spinecho MRI correlates with disease progression in multiple sclerosis,” Neurology, 47, 1469–1476 (1996).

M. A. van Walderveen, W. Kamphorst, P. Scheltens, et al., “Histopathologic correlate of hypointense lesions on T1-weighted spinecho MRI in multiple sclerosis,” Neurology, 50, 1282–1288 (1998).